These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11704218)

  • 21. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observation of heparin-induced thrombocytopenia].
    Tian HY; Meng Y; Zhang JB; Ma Q; Cheng GS; Fan FL; Wang J; Wan HM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1405-7. PubMed ID: 19671335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN; Rice L; Bartholomew JR; Whelton A
    Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.
    Turba UC; Bozlar U; Simsek S
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1046-50. PubMed ID: 18044775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-induced thrombocytopenia.
    Warkentin TE
    Dis Mon; 2005; 51(2-3):141-9. PubMed ID: 15900266
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
    Gleichgerrcht E; Lim MY; Turan TN
    Neurologist; 2017 Nov; 22(6):241-244. PubMed ID: 29095327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 36. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
    Pendleton R; Wheeler MM; Rodgers GM
    Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.